Institutional investors purchased a net $3.9 million shares of DEPO during the quarter ended March 2018 and now own 98.09% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 1.7 Million shares of Depomed Inc
RENAISSANCE TECHNOLOGIES LLC Bought 955.7 Thousand shares of Depomed Inc
QUANTITATIVE MANAGEMENT ASSOCIAT... Bought 790.8 Thousand shares of Depomed Inc